Edwards Lifesciences: Undervalued With A Substantial Upside Potential

burcu onter/iStock via Getty ImagesInvestment Thesis Edwards Lifesciences Corporation (NYSE:EW) is down 3.10% over the last year but I am bullish on the stock given its optimistic outlook for 2024 and beyond which I find very realistic and backed with strong levers. The company has a clear growth strategy, which I am confident will lead to long-term sustainable growth. Based on comparative analysis, EW appears to have higher growth rates and profitability ratios than competitors; something I believe und ...